Grants in the United States

Between cycles

Funds a phase 1 or small phase 2 ALS clinical trial that must start within a year of the award, with a biomarker built in for any drug, biologic or device.

Between cycles

Funds preclinical-to-IND-enabling work on an ALS drug that already has proof-of-concept efficacy data and a lead compound in hand.

Between cycles

Funds an early, hypothesis-driven ALS drug or therapy idea before there's data proving it will work.

Between cycles

Funds a human study of arthritis at whichever of two scales the evidence supports — a pilot or a full trial.

Between cycles

Funds preclinical or animal arthritis research that's too applied to count as basic science and not yet ready for people.

Between cycles

Funds a clinical trial of a new autism treatment, product or device, from a small proof-of-concept study up to a full efficacy trial.

Between cycles

Funds an innovative, high-risk autism research idea aimed at a critical problem or need, before there's a trial to run.

Between cycles

Funds breast cancer research mature enough to run a small clinical trial, though a trial is not required at this level.

Between cycles

Funds a single, large breast cancer research effort built around a clinical trial that has to happen.

Between cycles

Funds a large, multi-institution team of scientists, clinicians and advocates tackling one breast cancer problem too big for a single lab.

Between cycles

Funds preclinical or clinical Duchenne muscular dystrophy research, at a smaller or a larger funding level.

Between cycles

Funds an early-stage idea in Duchenne muscular dystrophy research, without requiring a clinical trial.

Between cycles

Funds drug discovery and therapy development for hearing loss from military-relevant injury, not tinnitus or balance disorders.

Between cycles

Funds an early-career researcher's kidney cancer project alongside paired mentoring inside the program's own investigator academy.

Between cycles

Funds an early-stage kidney cancer research idea built on a clear hypothesis and a strong scientific rationale.

Between cycles

Funds an early-stage, high-risk lung cancer research idea, with a separate track for investigators new to independent research.

Between cycles

Funds patient-centered research into lung cancer outcomes and survivorship, done alongside a patient or survivor advocate.

Between cycles

Funds translational lung cancer research moving toward the clinic, at either a late preclinical stage or a pilot clinical trial.

Between cycles

Funds a multi-investigator research program tackling one shared question in rare melanoma, split across two or three linked projects.

Between cycles

Funds an exploratory, high-risk melanoma research idea, where existing preliminary data is discouraged rather than expected.

Between cycles

Funds an early-career melanoma researcher's project alongside guided mentoring inside the program's own academy.

Between cycles

Funds research into the health, quality of life and well-being of melanoma survivors, their families and care partners.

Between cycles

Funds a multi-investigator melanoma research team through a pre-application screen, with each partner named on their own award.

Between cycles

Funds early, untested ideas in combat-relevant burn care meant to generate the preliminary data a later study would need.